Data Collection and Evaluation of OptiBP Under Investigational Use

Description

The purpose of this study is to collect data to develop and evaluate the use of state-of-the-art machine learning approaches within a mobile phone application for the estimation of blood pressure.

Conditions

General Population

Study Overview

Study Details

Study overview

The purpose of this study is to collect data to develop and evaluate the use of state-of-the-art machine learning approaches within a mobile phone application for the estimation of blood pressure.

Data Collection and Evaluation of a Mobile, Machine-learning-based Solution for Blood Pressure Estimation - the OptiBP Study.

Data Collection and Evaluation of OptiBP Under Investigational Use

Condition
General Population
Intervention / Treatment

-

Contacts and Locations

Truckee

Decentralized Trial, Truckee, California, United States, 96161

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Be at least 18 years old (at least 19 years old in Alabama and Nebraska, at least 21 years old in Puerto Rico);
  • 2. Live in the United States of America
  • 3. Have an Android smartphone
  • 4. Have access to an arm-worn blood pressure monitor (cuff)
  • 5. Have access to the Google Play store to download the OptiBP study app on their phone
  • 6. Be comfortable communicating in written and spoken English
  • 7. Be willing and able to provide informed consent to participate in the study
  • 1. Known contact dermatitis to nickel/chromium
  • 2. Lesion or deficiency on hand, preventing placing a finger on the smartphone camera
  • 3. Known dysrhythmia like bigeminy, trigeminy, isolated VPB, atrial fibrillation

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Biospectal,

Frederic Frappereau, PRINCIPAL_INVESTIGATOR, Biospectal

Study Record Dates

2026-09